Kathy M. Marker

726 total citations
8 papers, 572 citations indexed

About

Kathy M. Marker is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Urology. According to data from OpenAlex, Kathy M. Marker has authored 8 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 3 papers in Genetics and 2 papers in Urology. Recurrent topics in Kathy M. Marker's work include Prostate Cancer Diagnosis and Treatment (5 papers), Prostate Cancer Treatment and Research (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Kathy M. Marker is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (5 papers), Prostate Cancer Treatment and Research (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Kathy M. Marker collaborates with scholars based in United States. Kathy M. Marker's co-authors include Lisa S. Millar, Harry G. Rittenhouse, Lana S. Grauer, Roger L. Sokoloff, Stephen D. Mikolajczyk, Cindy L. Evans, Abhay Kumar, S D Mikolajczyk, Philip M. Carpenter and M S Saedi and has published in prestigious journals such as European Journal of Biochemistry, International Journal of Cancer and Clinical Chemistry.

In The Last Decade

Kathy M. Marker

8 papers receiving 546 citations

Peers

Kathy M. Marker

PRM

MB

RNMI

ONCOL

CR

Zuxiong Chen United States

Papsidero Ld

Robert T. Maguire United States

Edward W. Arfman United States

Penelope DeCarolis United States

Mari Peltola Finland

S. Vesalainen Finland

Paul A. Algate United States

Beatrice Knudsen United States

Maurizia Giai Italy

Zuxiong Chen United States

Kathy M. Marker

520 ×1.3

PRM

348 ×2.6

MB

52 ×0.5

RNMI

190 ×2.5

ONCOL

128 ×1.7

CR

Citations per year, relative to Kathy M. Marker Kathy M. Marker (= 1×) peers Zuxiong Chen

Countries citing papers authored by Kathy M. Marker

Since Specialization

Citations

This map shows the geographic impact of Kathy M. Marker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy M. Marker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy M. Marker more than expected).

Fields of papers citing papers by Kathy M. Marker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy M. Marker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy M. Marker. The network helps show where Kathy M. Marker may publish in the future.

Co-authorship network of co-authors of Kathy M. Marker

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy M. Marker. A scholar is included among the top collaborators of Kathy M. Marker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy M. Marker. Kathy M. Marker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Mikolajczyk, Stephen D., William J. Catàlona, Cindy L. Evans, et al.. (2004). Proenzyme Forms of Prostate-Specific Antigen in Serum Improve the Detection of Prostate Cancer. Clinical Chemistry. 50(6). 1017–1025. 117 indexed citations

2.

Saedi, Mohammad S., Zhu Zhu, Kathy M. Marker, et al.. (2001). Human kallikrein 2 (hK2), but not prostate‐specific antigen (PSA), rapidly complexes with protease inhibitor 6 (PI‐6) released from prostate carcinoma cells. International Journal of Cancer. 94(4). 558–563. 21 indexed citations

3.

Mikolajczyk, S D, Kathy M. Marker, Lisa S. Millar, et al.. (2001). A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer.. PubMed. 61(18). 6958–63. 156 indexed citations

4.

Sokoloff, Roger L., et al.. (2000). A dual-monoclonal sandwich assay for prostate-specific membrane antigen: Levels in tissues, seminal fluid and urine. The Prostate. 43(2). 150–157. 148 indexed citations

5.

Mikolajczyk, Stephen D., Lisa S. Millar, Kathy M. Marker, et al.. (2000). Seminal plasma contains ?BPSA,? a molecular form of prostate-specific antigen that is associated with benign prostatic hyperplasia. The Prostate. 45(3). 271–276. 46 indexed citations

6.

Mikolajczyk, Stephen D., Lisa S. Millar, Kathy M. Marker, et al.. (2000). Seminal plasma contains “BPSA,” a molecular form of prostate‐specific antigen that is associated with benign prostatic hyperplasia. The Prostate. 45(3). 271–276. 3 indexed citations

7.

Mikolajczyk, S D, Lisa S. Millar, Kathy M. Marker, et al.. (1999). Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissue.. PubMed. 59(16). 3927–30. 30 indexed citations

8.

Mikolajczyk, Stephen D., Lisa S. Millar, Kathy M. Marker, et al.. (1997). Ala217 is Important for the Catalytic Function and Autoactivation of Prostate‐Specific Human Kallikrein 2. European Journal of Biochemistry. 246(2). 440–446. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact